Question explored with the scientific record
Conversation so far
- 1 What is the expected timeline for post-vaccination encephalitis after MMR, Varicella, and Hep A vaccines assuming the encephalitis was caused by the vaccines?
- 2 Could 48 hours by theoretically plausible? How?
- 3 What immune mediated response could lead to encephalitis 48 hours post vaccination?
- 4 Do any vaccines support encephalitis at 48 hours?
- 5 Which vaccines had encephalitis onset closest to 48 hours?
- 6 What is the closest time range (in hours) reported for vaccine-related encephalitis?
Answered on this page ↓
What is the closest time range (in hours) reported for vaccine-related encephalitis?
The retrieved evidence does not contain any case of vaccine-related encephalitis with a reported onset time in hours.
The closest timing information is for MMR vaccine fever, which peaks at 9-10 days after vaccination [1]. That is about 216-240 hours, far from the 48-hour window. The same record-linkage study looked for encephalitis within 3 months of MMR vaccination, not within hours or days [1]. No other record in this retrieval reports any onset time for encephalitis after any vaccine.
The Korean background rate study [2] lists encephalitis as an adverse event of special interest for COVID-19 vaccines, but it reports only annual population incidence rates, not post-vaccination onset timing. The Tdap safety study [3] mentions encephalitis as a monitored neurologic event but gives no onset times at all.
My call: this retrieval provides no evidence for any vaccine-related encephalitis onset within any specific hour range, let alone one closest to 48 hours. Confidence: low — the retrieval simply does not address the question.
Sources used 3
-
MMR vaccine - how effective and how safe?
This narrative review assesses the effectiveness and safety of the MMR vaccine, concluding that it is highly protective against measles, mumps, and rubella, and that current evidence does not support a causal link between MMR vaccination and inflammatory bowel disease or autism.
DOI: 10.1136/dtb.2003.41425 -
Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in South Korea
Population-based analysis in Korea using the NHIS National Sample Cohort 2.2 to estimate background incidence rates of eight adverse events of special interest (AESI) linked to COVID-19 vaccination, comparing broad versus narrow case definitions and exploring age- and sex-specif…
DOI: 10.21032/jhis.2024.49.2.160 -
Additional Recommendations for Use of Tetanus Toxoid, Reduced-Content Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap)
Tdap can be given without a minimum interval after tetanus/diphtheria vaccines; Tdap is safe across age groups and broadly recommended, including undervaccinated children (7–10 years), health care personnel, and older adults.
DOI: 10.1542/peds.2011-1752